stockportfolio.pro
Arcus Biosciences, Inc. Revenue 2016–2025
Arcus Biosciences, Inc. (RCUS) annual revenue by fiscal year, computed from SEC filings.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $247.00M | -4.3% |
| FY 2024 | $258.00M | +120.5% |
| FY 2023 | $117.00M | +4.5% |
| FY 2022 | $112.00M | -70.8% |
| FY 2021 | $383.00M | +391.0% |
| FY 2020 | $78.00M | +420.0% |
| FY 2019 | $15.00M | +79.6% |
| FY 2018 | $8.35M | +491.2% |
| FY 2017 | $1.41M | — |
| FY 2016 | $0 | — |
Source: Arcus Biosciences, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Arcus Biosciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeArcus Biosciences, Inc. — frequently asked questions
What is Arcus Biosciences, Inc.'s revenue?
Arcus Biosciences, Inc. (RCUS) reported revenue of $247.00M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Arcus Biosciences, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.